SCHEMBL19973901

SCHEMBL19973901

O=C(O)N[C@H]1CCOc2c(C(=O)Nc3ccc(F)c(Cl)c3)ccc(SF)c21

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.42
MEN1 O00255 3/20 0.42
ALDH1A1 P00352 3/20 0.42
NPC1 O15118 4/20 0.41
RAB9A P51151 4/20 0.41
FADS1 O60427 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MALT1 Q9UDY8 1/20 0.39
SLC2A1 P11166 1/20 0.38
IDO1 P14902 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
NR1I2 O75469 1/20 0.37
AHR P35869 1/20 0.37
LMNA P02545 1/20 0.37
HTT P42858 1/20 0.37
GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19973615 1.00 KMT2A (0.42) KMT2AMEN1ALDH1A1NPC1RAB9A
SCHEMBL19973560 1.00 KMT2A (0.42) KMT2AMEN1ALDH1A1NPC1RAB9A
SCHEMBL19973956 0.92 MAOB (0.40) KMT2AMEN1ALDH1A1NPC1RAB9A
SCHEMBL19973883 0.92 MAOB (0.40) KMT2AMEN1ALDH1A1NPC1RAB9A
SCHEMBL19973551 0.92 MAOB (0.40) KMT2AMEN1ALDH1A1NPC1RAB9A
Hydrochloric Acid SCHEMBL19973581 0.91 MAOB (0.39) KMT2AMEN1ALDH1A1NPC1RAB9A
Hydrochloric Acid SCHEMBL19974003 0.91 MAOB (0.39) KMT2AMEN1ALDH1A1NPC1RAB9A
SCHEMBL19973456 0.91 KMT2A (0.46) KMT2AMEN1ALDH1A1NPC1RAB9A
SCHEMBL19973411 0.91 KMT2A (0.46) KMT2AMEN1ALDH1A1NPC1RAB9A
SCHEMBL19973410 0.91 KMT2A (0.46) KMT2AMEN1ALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same ARBUTUS BIOPHARMA CORPORATION (CA) 2021-05-11 US claimed
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (CA) 2019-07-25 US claimed
WO-2018052967-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA, INC. (US) 2018-03-22 WO claimed
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same ARBUTUS BIOPHARMA CORPORATION (CA) 2021-05-11 US disclosed
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (CA) 2019-07-25 US disclosed
WO-2018052967-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA, INC. (US) 2018-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME CBX8, HAVCR2, HCCS KMT2A 155/4885MEN1 1933/4885ALDH1A1 3241/4885
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same CBX8, HAVCR2, HCCS KMT2A 155/4885MEN1 1933/4885ALDH1A1 3241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.